Established in 2008, EntoGenex Industries Sdn Bhd (EntoGenex) is a biotechnology company focused on vector control. As a Malaysian-based company, EntoGenex is a pioneer in using green and sustainable solutions through the Integrated Mosquito Management (IMM) programme which is aimed at combating mosquito-transmitted diseases in Malaysia and worldwide.
Since then, EntoGenex has successfully incubated, developed and commercialised a range of mosquito control products utilising the Trypsin Modulating Oostatic Factor (TMOF) and EGX-101 technologies.
Our products utilising the TMOF and EGX-101 technologies have been successfully tested and their efficacy proven in field applications. Additionally, due to their safety, both technologies have been exempted from the registration requirement by the Malaysian Pesticide Board.
EntoGenex, biolarvicide products using TMOF are now supplied to the Ministry of Health in Malaysia, while insect repellent products using EGX-101 are used by the Malaysia’s Ministry of Defence and sold at retail outlets.
In 2009, EntoGenex was awarded the BioNexus status, an incentivised status to deserving biotechnology companies, from the Malaysian Biotechnology Corporation. The company is also a proud recipient of a RM 3.365 million TechnoFund Grant from the Ministry of Science, Technology and Innovation for the commercial development of its biopesticide products.
With its recent successes, EntoGenex is moving towards international expansion, promoting unique solutions in combating mosquito transmitted diseases onto a global platform.
Copyright © 2015
EntoGenex Industries Sdn Bhd.
All rights reserved.